4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 50,000 Value ($000) $375 Avg Close $10.14 Range $7.43 - $12.34
Q3 2025
Shares 50,000 Value ($000) $435 Avg Close $5.98 Range $3.68 - $8.72
Q2 2025
Shares 25,000 Value ($000) $93 Avg Close $3.52 Range $2.23 - $5.10
Q1 2025
Shares 12,484 Value ($000) $40 Avg Close $4.71 Range $3.17 - $6.91
Q4 2023
Shares 17,400 Value ($000) $353 Avg Close $13.16 Range $9.44 - $21.53
Q3 2023
Shares 27,400 Value ($000) $349 Avg Close $16.73 Range $12.34 - $20.47
Q2 2023
Shares 27,400 Value ($000) $495 Avg Close $18.41 Range $13.26 - $24.10
Q1 2023
Shares 27,400 Value ($000) $471 Avg Close $19.45 Range $14.67 - $23.81
Q4 2022
Shares 42,400 Value ($000) $942 Avg Close $15.45 Range $6.58 - $26.49
Q3 2022
Shares 57,400 Value ($000) $461 Avg Close $9.06 Range $6.70 - $11.95